CUTANEOUS T CELL LYMPHOMA (CTCL)
Clinical trials for CUTANEOUS T CELL LYMPHOMA (CTCL) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T CELL LYMPHOMA (CTCL) trials appear
Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMA (CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients as trial tests pill to control resistant cancer
Disease control Recruiting nowThis study is testing an oral medication called golidocitnib for people with slow-growing T/NK-cell lymphomas that have come back or haven't responded to prior treatments. The goal is to see if this once-daily pill can effectively shrink tumors and control the disease. Researcher…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists seek blood samples to unlock Leukemia's secrets
Knowledge-focused Recruiting nowThis study aims to collect blood, urine, and tissue samples from adults with certain blood cancers and from healthy volunteers. The goal is to study these samples in a lab to better understand diseases like hairy cell leukemia and to help develop future treatments. No treatment i…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC